Yahoo
NasdaqGS - Delayed Quote USD

Royalty Pharma plc (RPRX)

63.96 +0.08 (+0.13%)
At close: September 4 at 4:00:00 PM EDT
60.50 -3.46 (-5.41%)
After hours: September 4 at 7:55:13 PM EDT
Trade RPRX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
2,535,998
2,378,193
2,263,576
2,354,554
2,237,215
Operating Expense
954,861
818,675
971,132
862,404
1,314,323
Operating Income
1,581,137
1,559,518
1,292,444
1,492,150
922,892
Net Non Operating Interest Income Expense
-335,744
-274,073
-178,169
-114,896
-109,626
Other Income Expense
101,472
38,747
216,538
322,834
-583,202
Pretax Income
1,346,865
1,324,192
1,330,813
1,700,088
230,064
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
811,994
770,947
858,983
1,134,834
42,832
Average Dilution Earnings
233,718
234,575
276,893
392,726
--
Diluted NI Available to Com Stockholders
1,045,712
1,005,522
1,135,876
1,527,560
42,832
Basic EPS
1.87
1.80
1.93
2.54
0.10
Diluted EPS
1.86
1.37
1.45
2.53
0.10
Basic Average Shares
435,544
428,669
445,985
447,601
437,963
Diluted Average Shares
558,052.50
564,000
594,000
602,900
437,972
Total Operating Income as Reported
1,511,694
1,559,518
1,292,444
1,492,150
307,065
Total Expenses
954,861
818,675
971,132
862,404
1,314,323
Net Income from Continuing & Discontinued Operation
811,994
770,947
858,983
1,134,834
42,832
Normalized Income
742,868
746,940
670,528
819,145
602,306
Interest Income
25,330
33,591
47,343
72,291
78,335
Interest Expense
361,074
307,664
225,512
187,187
187,961
Net Interest Income
-335,744
-274,073
-178,169
-114,896
-109,626
EBIT
1,707,939
1,631,856
1,556,325
1,887,275
418,025
EBITDA
1,712,877
1,635,708
1,556,325
1,887,275
423,695
Reconciled Depreciation
4,938
3,852
0
0
5,670
Net Income from Continuing Operation Net Minority Interest
811,994
770,947
858,983
1,134,834
42,832
Total Unusual Items Excluding Goodwill
69,126
24,007
188,455
315,689
-559,474
Total Unusual Items
69,126
24,007
188,455
315,689
-559,474
Normalized EBITDA
1,643,751
1,611,701
1,367,870
1,571,586
983,169
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 6/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: